Aztreonam Injection, Powder, Lyophilized, For Solution
Product Images NDC 0409-0830

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Aztreonam (NDC 0409-0830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Aztreonam 01)

Chemical structure diagram of aztreonam, showing its molecular arrangement including functional groups and rings typical for the antibiotic compound aztreonam.*

FDA Label Image

Figure 1 (Aztreonam 02)

A pharmacokinetic curve showing aztreonam serum concentration (mcg/mL) over time (hours) for different doses and routes of administration, including 500 mg, 1 g, and 2 g given intravenously (IV) and intramuscularly (IM). Concentration decreases over time for all conditions.*

FDA Label Image

Logo (Aztreonam 03)

FDA Label Image

Principal Display Panel (1 gram Vial Label)

Label for Aztreonam for Injection, USP 1 gram per vial, a lyophilized powder for injection by Hospira, Inc. The single-dose vial label includes storage instructions (20°C to 25°C) and specifies use for intravenous or intramuscular injection after constitution. The label also features lot and expiration date placeholders, a barcode, and distributor information.*

FDA Label Image

Principal Display Panel (1 gram Vial Carton)

Packaging label for Aztreonam for Injection, USP 1 gram/vial, a lyophilized powder for injection. The label indicates it is for intravenous or intramuscular use after constitution and includes storage instructions (20°C to 25°C). The package contains 10 single-dose vials and is distributed by Hospira, Inc. The product is made in Australia.*

FDA Label Image

Principal Display Panel (2 gram Vial Label)

Aztreonam for Injection, USP 2 grams/vial label for lyophilized powder for injection. The vial is indicated for intravenous or intramuscular use after constitution. Distributed by Hospira, Inc. The label includes storage instructions at 20°C to 25°C and notes the vial contains 2 grams aztreonam with approximately 1.56 grams arginine, sodium-free.*

FDA Label Image

Principal Display Panel (2 gram Vial Carton)

Packaging label for Aztreonam for Injection, USP, 2 grams per vial. The label shows it is a lyophilized powder for injection available as single-dose vials with intravenous or intramuscular use after constitution. Distributed by Hospira, Inc. and made in Australia. The package indicates storage conditions and usage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.